Literature DB >> 24345473

Cognitive symptoms in patients with major depressive disorder and their implications for clinical practice.

George I Papakostas1.   

Abstract

CONTEXT: The literature regarding cognitive symptoms in major depressive disorder (MDD) is vast and often contradictory. To provide clinicians with a concise understanding of these prevalent and disabling symptoms, this overview describes what is known regarding cognitive symptoms in patients with MDD, the limitations of the current literature, and the implications of these data for current and future clinical practice. EVIDENCE ACQUISITION: PubMed searches were conducted to identify studies, meta-analyses, and systematic reviews evaluating cognitive function (not cognitive bias) in patients with MDD. Search terms used in combination with MDD were cognition, cognitive dysfunction, memory, psychomotor processing, and executive function. Searches were limited to articles available in the English language and those published between April 2007 and March 2012. Additional studies and those describing screening tools were identified using reference lists and PubMed "related citations." Ongoing trials were identified by searching for cognitive dysfunction and MDD at www.ClinicalTrials.gov. Relevant articles were obtained and reviewed by the author.
RESULTS: Small sample size and inconsistent assessment tools were identified as major limitations of studies assessing clinical characteristics and risk factors for cognitive symptoms. Meta-analyses and systematic reviews were used to mitigate this limitation.
CONCLUSIONS: Cognitive symptoms of depression are prevalent and associated with earlier illness onset and longer episode duration. They can have an adverse impact on the treatment course of MDD as well as on functional recovery in depression. Further studies are needed to help determine whether certain treatments can be more effective than others at targeting these symptoms. © Copyright 2014 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2014        PMID: 24345473     DOI: 10.4088/JCP.13r08710

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  36 in total

Review 1.  The prevalence, measurement, and treatment of the cognitive dimension/domain in major depressive disorder.

Authors:  Roger S McIntyre; Holly X Xiao; Kahlood Syeda; Maj Vinberg; Andre F Carvalho; Rodrigo B Mansur; Nadia Maruschak; Danielle S Cha
Journal:  CNS Drugs       Date:  2015-07       Impact factor: 5.749

Review 2.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 1. Disease Burden and Principles of Care.

Authors:  Raymond W Lam; Diane McIntosh; JianLi Wang; Murray W Enns; Theo Kolivakis; Erin E Michalak; Jitender Sareen; Wei-Yi Song; Sidney H Kennedy; Glenda M MacQueen; Roumen V Milev; Sagar V Parikh; Arun V Ravindran
Journal:  Can J Psychiatry       Date:  2016-08-02       Impact factor: 4.356

Review 3.  Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder.

Authors:  G I Papakostas; D F Ionescu
Journal:  Mol Psychiatry       Date:  2015-07-07       Impact factor: 15.992

4.  Emotional Blunting, Cognitive Impairment, Bone Fractures, and Bleeding as Possible Side Effects of Long-Term Use of SSRIs.

Authors:  Donatella Marazziti; Federico Mucci; Beniamino Tripodi; Manuel Glauco Carbone; Alessia Muscarella; Valentina Falaschi; Stefano Baroni
Journal:  Clin Neuropsychiatry       Date:  2019-04

5.  Artificially-reconstructed brain images with stroke lesions from non-imaging data: modeling in categorized patients based on lesion occurrence and sparsity.

Authors:  Stephanie Sutoko; Hirokazu Atsumori; Akiko Obata; Ayako Nishimura; Tsukasa Funane; Masashi Kiguchi; Akihiko Kandori; Koji Shimonaga; Seiji Hama; Toshio Tsuji
Journal:  Sci Rep       Date:  2022-06-16       Impact factor: 4.996

6.  'I was thinking too much': experiences of HIV-positive adults with common mental disorders and poor adherence to antiretroviral therapy in Zimbabwe.

Authors:  Khameer Kidia; Debra Machando; Tarisai Bere; Kirsty Macpherson; Primrose Nyamayaro; Lucy Potter; Tariro Makadzange; Ronald Munjoma; Marshall Marufu; Ricardo Araya; Steven Safren; Conall O'Cleirigh; Dixon Chibanda; Melanie Abas
Journal:  Trop Med Int Health       Date:  2015-03-23       Impact factor: 2.622

Review 7.  Multifactorial determinants of the neurocognitive effects of electroconvulsive therapy.

Authors:  Shawn M McClintock; Jimmy Choi; Zhi-De Deng; Lawrence G Appelbaum; Andrew D Krystal; Sarah H Lisanby
Journal:  J ECT       Date:  2014-06       Impact factor: 3.635

8.  Autonomic Nervous System Is Related to Inhibitory and Control Function Through Functional Inter-Region Connectivities of OFC in Major Depression.

Authors:  Hongliang Zhou; Lingling Hua; Haiteng Jiang; Zongpeng Dai; Yinglin Han; Pinhua Lin; Haofei Wang; Qing Lu; Zhijian Yao
Journal:  Neuropsychiatr Dis Treat       Date:  2020-01-21       Impact factor: 2.570

9.  Safety and tolerability of vortioxetine (15 and 20 mg) in patients with major depressive disorder: results of an open-label, flexible-dose, 52-week extension study.

Authors:  Paula L Jacobsen; Linda Harper; Lambros Chrones; Serena Chan; Atul R Mahableshwarkar
Journal:  Int Clin Psychopharmacol       Date:  2015-09       Impact factor: 1.659

10.  Effects of psychiatric history on cognitive performance in old-age depression.

Authors:  Alexandra Pantzar; Anna Rita Atti; Lars Bäckman; Erika J Laukka
Journal:  Front Psychol       Date:  2015-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.